Sebastian E. Beyer MD, MPH, Christian Sohns MD, Philipp Sommer MD
{"title":"Atrial Fibrillation in End-Stage Heart Failure","authors":"Sebastian E. Beyer MD, MPH, Christian Sohns MD, Philipp Sommer MD","doi":"10.1016/j.ccep.2024.07.004","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":39250,"journal":{"name":"Cardiac Electrophysiology Clinics","volume":"17 1","pages":"Pages 87-97"},"PeriodicalIF":0.0000,"publicationDate":"2024-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cardiac Electrophysiology Clinics","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S187791822400039X","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
终末期心力衰竭的心房颤动。
终末期心力衰竭(HF)占所有HF病例的1%至10%。由于血流动力学改变、壁应力增加和神经激素激活相关的结构改变,它经常与共存的心房颤动相关。由于频繁的心房重构、合并症和高复发率,治疗仍然具有挑战性。研究发现,与心率控制相比,医学节律控制没有任何好处。然而,最近的数据表明,导管消融可能与心衰症状和全因死亡率的降低有关。其他治疗方案包括房室结消融可用于难治性病例,但不应延误紧急心脏移植。
本文章由计算机程序翻译,如有差异,请以英文原文为准。